Higher levels of NT-proBNP were associated with an increased risk of thromboembolic events and cardiovascular mortality in AF patients, supporting the function of NT-proBNP as a predictive marker for these outcomes [72]. This evidence concerns the gene NPPB and atrial fibrillation.